Medical/Pharmaceuticals

CLASSYS Appoints Former Bain & Company Partner Jung-hee Bae as Chief Commercial Officer to Accelerate Global Expansion and Growth

- Appoints Vice President Jung-hee Bae to lead the newly established Go-to-Market (GTM) Center, overseeing domestic and international sales and marketing - AI and data-driven marketing and operations expert to spearhead expansion across the Americas, China and Europe while reinforcing the company...

2026-10-12 14:49 4146

Three Korean Deep-Tech Firms Seek Singapore Partners in October

The pre-screened companies span smart-city positioning, AI cardiac screening and functionalcoatings,withSingaporemeetingsplannedfor26-29October. SINGAPORE, Oct. 12, 2026 /PRNewswire/ -- Three technology companies supported by the Incheon Center for Creative Economy & Innovation (Incheon CCEI) - I...

2026-10-12 10:00 4623

Celltrion to Present New Analyses of ZYMFENTRA® (infliximab-dyyb) in Crohn's Disease and Ulcerative Colitis at ACG 2026

* New data show favorable outcomes with subcutaneous infliximab following intravenous infliximab interruption, regardless of prior antibody status, in adult patients with moderate to severely active Crohn's disease and ulcerative colitis * Late-breaking analysis shows significantly higher rat...

2026-10-12 01:00 4267

New Opportunities for Global Cooperation: Kexing Biopharm Shines at CPHI Milan 2026

MILAN, Oct. 10, 2026 /PRNewswire/ -- From October 06 to 08, 2026, Kexing Biopharm (688136.SH) exhibited at CPHI Milan 2026, showcasing its global innovative drug pipeline, co-developed biosimilars, and a broad portfolio of products commercialized in overseas markets. During the event, the Company...

2026-10-10 16:06 5193

First Patient Dosed in Phase III Perioperative Study of Cadonilimab (PD-1/CTLA-4) in Colon Cancer

HONG KONG, Oct. 10, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that the first patient has been dosed in a Phase III clinical study (COMPASSION-40/AK104-313) evaluating cadonilimab, its first-in-class PD-1/CTLA-4 bispecific antibody, as monotherapy in the neoa...

2026-10-10 12:41 3556

POMDOCTOR LIMITED Announces Receipt of Nasdaq Staff Delisting Determination

GUANGZHOU, China, Oct. 9, 2026 /PRNewswire/ -- POMDOCTOR LIMITED ("Pomdoctor" or the "Company") (Nasdaq: POM), a digital healthcare company focused on advancing AI-enabled healthcare solutions and predictive healthcare capabilities, today announced that it received a staff determination letter (...

2026-10-10 04:05 4320

Invetech & MeMed win 2026 Good Design Award Gold for MeMed Key™

Award recognizes innovation, design excellence, and impact in Engineering Design SAN DIEGO, Oct. 9, 2026 /PRNewswire/ -- Invetech, a product realization company that designs, engineers and manufactures fully customizable platforms, announced that its work on the MeMed Key™ has been recognized wit...

2026-10-10 04:00 2913

MIDEA COMPLETES THE ACQUISITION OF ESAOTE

Midea Group marks its commitment to healthcare and innovation by completing the acquisition of Esaote   GENOA, Italy, Oct. 9, 2026 /PRNewswire/ -- Esaote S.p.A., a leader in the medical imaging sector, announces the completion of the controlling stake acquisition of its share capital by Midea – ...

2026-10-09 18:00 2832

Dr. Vein, a Specialist Varicose Vein Clinic in Ho Chi Minh City, Sets Out Its Treatment Pathway for Patients Travelling from the United States

HO CHI MINH CITY, Vietnam, Oct. 9, 2026 /PRNewswire/ -- Dr. Vein Clinic, a medical facility in central Ho Chi Minh City specializing in the examination and treatment of varicose veins, has set out the treatment pathway it uses for patients who travel to Vietnam for care. The clinic treats lower l...

2026-10-09 16:43 5827

India Mental Health Alliance (IMHA) champions lived experience as central to shaping mental healthcare practice, service design and policy

NEW DELHI, Oct. 9, 2026 /PRNewswire/ -- On the occasion of World Mental Health Day (10th October), the India Mental Health Alliance (IMHA), a cross-sectoral network of 400 organisations from 30 Indian states, reaffirms its commitment to recognising lived experience as expertise, ensuring that the...

2026-10-09 16:00 4502

Antengene to Present Latest Preclinical Results of ATG-207 (αCD3-TGF-β Bifunctional Fusion Protein) at ACR 2026

SHANGHAI and HONG KONG, Oct. 9, 2026 /PRNewswire/ -- Antengene Corporation Limited  ("Antengene", SEHK: 6996.HK) , a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune di...

2026-10-09 11:22 5147

Everest Medicines Appoints Two Veteran mRNA Cancer Vaccine Scientists to Advance Global Clinical Development

* Lakshmi Srinivasan, PhD, former Executive Director and Head of Oncology Translational Medicine at Moderna, and Brandon Coder, PhD, former Research & Early Translational Lead, Cancer Vaccines at Moderna, join Everest Medicines * Appointments support continued advancement of Everest's mRNA pip...

2026-10-09 10:15 6361

Innovent Announces Phase 3 RESTORE-3 Study of SYCUME® (Teprotumumab N01 Injection) Met Primary Endpoint in Inactive Thyroid Eye Disease

* SYCUME® Significantly Improved Proptosis (Response Rate 60.4% / LS Mean Change from Baseline -1.88 mm) with Favorable Safety Profile in Participants with Inactive Thyroid Eye Disease(TED) SAN FRANCISCO and SUZHOU, China, Oct. 8, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX...

2026-10-09 08:00 4485

Telix to Host Capital Markets Day in Melbourne on November 4, 2026

MELBOURNE, Australia and INDIANAPOLIS, Oct. 9, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announced that it will host a Capital Markets Day in Melbourne, Australia, on Wednesday, November 4, 2026, from 9:00 a.m. to 12:30 p.m. (AEDT). Institutional i...

2026-10-09 04:00 2707

GenScript Launches Life Sciences Startup PitchFest with NVIDIA to Accelerate Biotech Innovation

Inaugural competition will connect emerging AI life sciences platforms with validation expertise, investors, and ecosystem partners during JPM Week PISCATAWAY, N.J. and SANTA CLARA, Calif., Oct. 8, 2026 /PRNewswire/ -- GenScript Biotech Corporation

2026-10-08 22:01 2800

Wellysis Secures FDA 510(k) Clearance for AI-Powered ECG Analysis Software, S-Patch CardioAI

* Adds FDA-cleared AI analysis to Wellysis' S-Patch ECG monitoring solution, expanding its capabilities beyond ECG acquisition * Enables FDA-cleared AI analysis of S-Patch ECG data to be integrated into third-party ECG platforms and existing clinical workflows * Designed to streamline ECG re...

2026-10-08 22:00 4867

China SXT Pharmaceuticals Inc. Announces $12 Million Registered Direct Offering

TAIZHOU, China, Oct. 8, 2026 /PRNewswire/ -- China SXT Pharmaceuticals Inc. (NASDAQ: SXTC) (the "Company"), today announced that it has entered into a definitive agreement with certain institutional investors for the purchase and sale of an aggregate of 8,000,000 Class A ordinary shares of the co...

2026-10-08 21:22 6969

SECuRE update: recruitment target of the Cohort Expansion Main Group achieved

SYDNEY, Oct. 8, 2026 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with cancer, is pleased to announce that the recruitment t...

2026-10-08 21:01 3139

Helfie Signs MOU with Homa Bay Kenya Ministry of Health for TB and Hypertension Screening Pilot

Population-scale pilot will target 100,000 of Homa Bay's most vulnerable people  across five sub-counties. MELBOURNE, Australia, Oct. 8, 2026 /PRNewswire/ -- Helfie AI ("Helfie"), an AI-powered preventive network transforming global healthcare, today announced it has signed a Memorandum of Unders...

2026-10-08 21:00 3122
1 ... 11121314151617 ... 643